Dianthus Therapeutics, Inc.

DNTH· Nasdaq

Since Oct 4, 2025

Transactions: 66
Purchases: 0
Sales: 66
Purchase value: $0.00
Sale value: $71.19M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Carr EdwardCHIEF ACCOUNTING OFFICER

4Rule 10b5-1 plan disclosed

Filed Sep 18, 2026Period of report Sep 17, 20260001273351-26-000006

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
SaleSep 17, 2026	Common Stock^F1^F2	7,928	$100.43	$796.21K	12,072	Direct
SaleSep 17, 2026	Common Stock^F1^F3	6,771	$101.37	$686.38K

Filing footnotes · 7

F1The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 18, 2026.
F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $99.98 to $100.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F3The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $100.99 to $101.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $101.99 to $102.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F5The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $103.05 to $103.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F6The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $104.17 to $104.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F7The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Open on SEC EDGAR

Randhawa SimratEVP, Head of R&D

4Rule 10b5-1 plan disclosed

Filed Sep 3, 2026Period of report Sep 1, 20260001992260-26-000009

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Read SimonDirector

4Rule 10b5-1 plan disclosed

Filed Aug 19, 2026Period of report Aug 19, 20260001688199-26-000006

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

McGeorge AnneDirector

4Rule 10b5-1 plan disclosed

Filed Aug 11, 2026Period of report Aug 10, 20260001779934-26-000004

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Veness Adam MSVP, General Counsel and Sec.

4Rule 10b5-1 plan disclosed

Filed Aug 11, 2026Period of report Aug 7, 20260001778623-26-000007

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Read SimonDirector

4Rule 10b5-1 plan disclosed

Filed Aug 11, 2026Period of report Aug 10, 20260001688199-26-000004

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Garcia MarinoDirector · CEO AND PRESIDENT

4Rule 10b5-1 plan disclosed

Filed Aug 7, 2026Period of report Aug 7, 20260001669866-26-000010

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Savitz RyanEVP, CFO & CBO

4Rule 10b5-1 plan disclosed

Filed Jul 13, 2026Period of report Jul 9, 20260001992324-26-000008

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Veness Adam MSVP, General Counsel and Sec.

4Rule 10b5-1 plan disclosed

Filed Jun 18, 2026Period of report Jun 17, 20260001778623-26-000005

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Randhawa SimratEVP, Head of R&D

4Rule 10b5-1 plan disclosed

Filed Jun 2, 2026Period of report Jun 1, 20260001992260-26-000006

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Soteropoulos PaulaDirector

4Rule 10b5-1 plan disclosed

Filed May 11, 2026Period of report May 8, 20260001692444-26-000008

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Savitz RyanEVP, CFO & CBO

4Rule 10b5-1 plan disclosed

Filed Apr 10, 2026Period of report Apr 9, 20260001992324-26-000006

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Savitz RyanEVP, CFO & CBO

4Rule 10b5-1 plan disclosed

Filed Apr 1, 2026Period of report Mar 31, 20260001992324-26-000004

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Soteropoulos PaulaDirector

4Rule 10b5-1 plan disclosed

Filed Apr 1, 2026Period of report Mar 31, 20260001692444-26-000006

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Soteropoulos PaulaDirector

4Rule 10b5-1 plan disclosed

Filed Mar 26, 2026Period of report Mar 24, 20260001692444-26-000003

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Randhawa SimratEVP, Head of R&D

4Rule 10b5-1 plan disclosed

Filed Mar 13, 2026Period of report Mar 12, 20260001992260-26-000004

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Garcia MarinoDirector · CEO AND PRESIDENT

4Rule 10b5-1 plan disclosed

Filed Mar 13, 2026Period of report Mar 12, 20260001669866-26-000005

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Carr EdwardCHIEF ACCOUNTING OFFICER

4Rule 10b5-1 plan disclosed

Filed Mar 13, 2026Period of report Mar 12, 20260001273351-26-000004

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Savitz RyanCFO & CBO

4Rule 10b5-1 plan disclosed

Filed Dec 5, 2025Period of report Dec 4, 20250001992324-25-000005

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Randhawa SimratEVP, Head of R&D

4Rule 10b5-1 plan disclosed

Filed Nov 14, 2025Period of report Nov 13, 20250001992260-25-000008

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.

Filing footnotes · 6

F1The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 11, 2026.
F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $106.79 to $107.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F3The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $107.84 to $108.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $108.89 to $109.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F5The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $110.05 to $111.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F6The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $111.15 to $111.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Filing footnotes · 8

F1The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026.
F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $106.50 to $107.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F3The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $107.54 to $108.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $108.54 to $109.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F5The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $109.55 to $110.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F6The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $110.56 to $111.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F7The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $111.57 to $111.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F8The shares of common stock underlying this stock option award vest as to one-third of the shares subject to the option on each of the first, second and third anniversaries of the date of grant, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Filing footnotes · 8

F1The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026.
F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $106.68 to $107.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F3The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $107.68 to $108.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $108.74 to $109.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F5The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $109.75 to $110.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.52 to $108.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
F7The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $108.57 to $108.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F8The shares of common stock underlying this stock option award vested as to 25% of the shares on November 1, 2022, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Filing footnotes · 8

F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.
F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.17 to $90.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F3The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.17 to $91.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.17 to $91.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F5The shares of common stock underlying this stock option award vested as to 25% of the shares on April 25, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
F6The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
F7The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after May 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
F8The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Filing footnotes · 11

F1The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025.
F10The shares of common stock underlying this stock option award vested as to 25% of the shares on June 2, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
F11The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.74 to $78.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F3The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.74 to $79.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.11 to $81.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F5The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.15 to $81.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F6The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.25 to $83.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F7The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $83.25 to $84.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F8The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $84.25 to $85.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F9The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.25 to $85.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Filing footnotes · 8

F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.
F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.48 to $36.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F3The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.48 to $37.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.48 to $38.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
F5The shares of common stock underlying this stock option award vested as to 25% of the shares on April 25, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
F6The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
F7The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after May 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
F8The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date.